<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04334473</url>
  </required_header>
  <id_info>
    <org_study_id>N-45-2019</org_study_id>
    <nct_id>NCT04334473</nct_id>
  </id_info>
  <brief_title>IOP and Ocular Biometrics Changes After Phacoemulsification in Glaucoma Patients and Controls</brief_title>
  <official_title>Intraocular Pressure and Ocular Biometrics Changes After Phacoemulsification in Glaucomatous Patients and Age Matched Controls, Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mai Nasser Abd Elmohsen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasr El Aini Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Effect of phacoemulsification on intraocular pressure has been studied with variable
      results.Furthermore, effect of phacoemulsification on ocular biometrics including anterior
      chamber depth and angle opening distance has also been studied. In our study we aim at
      establishing a quantitative relationship between preoperative ocular biometrics and
      postoperative intraocular pressure change and comparing this relationship in glaucomatous and
      non-glaucomatous eyes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients will have the anterior chamber angle assessed by indentation gonioscopy
      preoperatively. Anterior Chamber Depth &amp; lens thickness will be measured by Optical Biometry
      (lenstar 900) as well as measurement of the angle &amp; lens vault using the Ultrasound
      Biomicrosopy (UBM) before and 1 month after cataract surgery. IOP will be measured pre- &amp;
      postoperatively on day 7 and 30. Possible Risk (s): Risks of surgery(hemorrhage,
      endophthalmitis), Risks for investigations: minimal risk of infection To minimize the risk of
      infection: adherence to pre-&amp; intraoperative infection-control measures, postoperative UBM is
      to be done at 1 month.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 20, 2019</start_date>
  <completion_date type="Actual">April 1, 2020</completion_date>
  <primary_completion_date type="Actual">March 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All participants are assigned to the same interventions. All will undergo pre- &amp; postoperative assessment, cataract surgery.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraocular pressure change</measure>
    <time_frame>4 weeks</time_frame>
    <description>intraocular pressure measurement by Goldman's applanation tonometr</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ocular bio-metrics change</measure>
    <time_frame>4 weeks</time_frame>
    <description>anterior chamber angle angle opening distance and anterior chamber depth change</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Phacoemulsification as treatment to glaucoma</measure>
    <time_frame>4 weeks</time_frame>
    <description>intraocular pressure decrease after surgery in glaucoma patients</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">37</enrollment>
  <condition>Glaucoma</condition>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>cataract patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients having cataract candidates for phacoemulsification with or without glaucoma are prepared to do cataract surgery with preoperative and postoperative assessment of intraocular pressure and ocular bio-metrics using UBM.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>phacoemulsification and Intraocular lens implantation</intervention_name>
    <description>Standartd surgical procedure with small incision to remove catarct using ultrasound waves. it can be done by topica, local or general anaesthesia acoording to patients general fitness and preference.</description>
    <arm_group_label>cataract patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ultrasound Biomicrosopy (UBM)</intervention_name>
    <description>A diagnostic test using ultrasound waves to evaluate the anterior chamber depth, angle and lens vault.</description>
    <arm_group_label>cataract patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 40-70 years.

          -  Glaucomtous and nonglaucomatous participants with visually significant cataracts.

          -  Best-corrected visual acuity (BCVA) equal to or worse than 6/12.

          -  patients candidates for standard cataract surgeries without adjunctive procedure
             (e.g., pupil stretching or iris hooks).

        Exclusion Criteria:

          -  Major intraoperative or postoperative complications from cataract surgery

          -  Peripheral anterior synechiae (PAS) detected by indentation gonioscopy.

          -  Uveitis, severe retinal diseases, or congenital Anomalies.

          -  History of ocular trauma or any intraocular Surgery. ocular trauma or any intraocular
             Surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karim A Raafat, MD</last_name>
    <role>Study Director</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of medicine, Cairo university</name>
      <address>
        <city>Cairo</city>
        <zip>11562</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Elgin U, Şen E, Şimşek T, Tekin K, Yılmazbaş P. Early Postoperative Effects of Cataract Surgery on Anterior Segment Parameters in Primary Open-Angle Glaucoma and Pseudoexfoliation Glaucoma. Turk J Ophthalmol. 2016 Jun;46(3):95-98. Epub 2016 Jun 6.</citation>
    <PMID>27800269</PMID>
  </reference>
  <results_reference>
    <citation>Melancia D, Abegão Pinto L, Marques-Neves C. Cataract surgery and intraocular pressure. Ophthalmic Res. 2015;53(3):141-8. doi: 10.1159/000377635. Epub 2015 Mar 7. Review.</citation>
    <PMID>25765255</PMID>
  </results_reference>
  <results_reference>
    <citation>Hsu CH, Kakigi CL, Lin SC, Wang YH, Porco T, Lin SC. Lens Position Parameters as Predictors of Intraocular Pressure Reduction After Cataract Surgery in Nonglaucomatous Patients With Open Angles. Invest Ophthalmol Vis Sci. 2015 Dec 1;56(13):7807-7813. doi: 10.1167/iovs.15-17926.</citation>
    <PMID>26650901</PMID>
  </results_reference>
  <results_reference>
    <citation>Man X, Chan NC, Baig N, Kwong YY, Leung DY, Li FC, Tham CC. Anatomical effects of clear lens extraction by phacoemulsification versus trabeculectomy on anterior chamber drainage angle in primary angle-closure glaucoma (PACG) patients. Graefes Arch Clin Exp Ophthalmol. 2015 May;253(5):773-8. doi: 10.1007/s00417-015-2936-z. Epub 2015 Feb 3.</citation>
    <PMID>25644619</PMID>
  </results_reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 2, 2020</study_first_submitted>
  <study_first_submitted_qc>April 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 6, 2020</study_first_posted>
  <last_update_submitted>April 2, 2020</last_update_submitted>
  <last_update_submitted_qc>April 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Kasr El Aini Hospital</investigator_affiliation>
    <investigator_full_name>Mai Nasser Abd Elmohsen</investigator_full_name>
    <investigator_title>Lecturer of ophthalmology</investigator_title>
  </responsible_party>
  <keyword>Ocular bio-metrics</keyword>
  <keyword>Anterior chamber depth</keyword>
  <keyword>UBM</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 14, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/73/NCT04334473/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 14, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/73/NCT04334473/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

